Literature DB >> 33411805

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other places of China.

Shuhui Duan1, Meiying Zhou2, Wen Zhang2, Jianwei Shen2, Rui Qi3, Xiangrong Qin4, Hao Yu1, Chuanmin Zhou1, Qing Hu2, Xue-Jie Yu1.   

Abstract

Wuhan City (WH) in China was the first place to report COVID-19 in the world and the outbreak of COVID-19 was controlled in March of 2020 in WH. It is unclear what percentage of people were infected with SARS-CoV-2 and what percentage of population is carriers of SARS-CoV-2 in WH. We retrospectively analyzed the SARS-CoV-2 IgG and IgM antibody positive rates in 63,107 healthy individuals from WH and other places of China using commercial colloidal gold detection kits from March 6 to May 3, 2020. Statistical approaches were utilized to explore the difference and correlation for the seropositive rate of IgG and IgM antibody on the basis of sex, age group, geographic region and detection date. The total IgG and IgM antibody positive rate of SARS-CoV-2 was 1.68% (186/11,086) in WH, 0.59% (226/38,171) in Hubei Province without Wuhan (HB), and 0.38% (53/13,850) in the nation except for Hubei Province (CN), respectively. The IgM positive rate was 0.46% (51/11,086) in WH, 0.13% (51/38,171) in HB, and 0.07% (10/13,850) in CN. The incidence of IgM positive rates in healthy individuals increased from March 6 to May 3, 2020 in WH. Female and older age had a higher probability of becoming infected than males (OR = 1.34; 95% CI: 1.08-1.65) or younger age (OR = 2.25; 95% CI: 1.06-4.78). The seroprevalence of SARS-CoV-2 was relatively low in WH and other places of China, but it is significantly high in WH than other places of China; a large amount of asymptomatic carriers of SARS-CoV-2 existed after elimination of clinical cases of COVID-19 in Wuhan City. Therefore, SARS-CoV-2 may exist in a population without clinical cases for a long period.

Entities:  

Year:  2021        PMID: 33411805      PMCID: PMC7790301          DOI: 10.1371/journal.pntd.0008975

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  16 in total

1.  Clinical evaluation of a rapid colloidal gold immunochromatography assay for SARS-Cov-2 IgM/IgG.

Authors:  Bo Shen; Yufen Zheng; Xiaoyan Zhang; Weituo Zhang; Donglian Wang; Jie Jin; Rong Lin; Ying Zhang; Guangjun Zhu; Hongguo Zhu; Jun Li; Jiaqin Xu; Xianhong Ding; Shiyong Chen; Ruyue Lu; Zebao He; Haihong Zhao; Lingjun Ying; Chao Zhang; Dongqing Lv; Baofu Chen; Jiya Chen; Jiansheng Zhu; Bingjie Hu; Chenliang Hong; Xiangyu Xu; Jiaxi Chen; Chong Liu; Kai Zhou; Jing Li; Guoling Zhao; Weixiang Shen; Chunfeng Chen; Chunyan Shao; Xiaoying Shen; Jingjing Song; Zhipeng Wang; Ying Meng; Chao Wang; Junsong Han; Aojun Chen; Daru Lu; Biyun Qian; Haixiao Chen; Hengjun Gao
Journal:  Am J Transl Res       Date:  2020-04-15       Impact factor: 4.060

2.  Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China.

Authors:  Xin Xu; Jian Sun; Sheng Nie; Huiyuan Li; Yaozhong Kong; Min Liang; Jinlin Hou; Xianzhong Huang; Dongfeng Li; Tean Ma; Jiaqing Peng; Shikui Gao; Yong Shao; Hong Zhu; Johnson Yiu-Nam Lau; Guangyu Wang; Chunbao Xie; Li Jiang; Ailong Huang; Zhenglin Yang; Kang Zhang; Fan Fan Hou
Journal:  Nat Med       Date:  2020-06-05       Impact factor: 53.440

3.  Antibody responses to SARS-CoV-2 in patients with COVID-19.

Authors:  Quan-Xin Long; Bai-Zhong Liu; Hai-Jun Deng; Gui-Cheng Wu; Kun Deng; Yao-Kai Chen; Pu Liao; Jing-Fu Qiu; Yong Lin; Xue-Fei Cai; De-Qiang Wang; Yuan Hu; Ji-Hua Ren; Ni Tang; Yin-Yin Xu; Li-Hua Yu; Zhan Mo; Fang Gong; Xiao-Li Zhang; Wen-Guang Tian; Li Hu; Xian-Xiang Zhang; Jiang-Lin Xiang; Hong-Xin Du; Hua-Wen Liu; Chun-Hui Lang; Xiao-He Luo; Shao-Bo Wu; Xiao-Ping Cui; Zheng Zhou; Man-Man Zhu; Jing Wang; Cheng-Jun Xue; Xiao-Feng Li; Li Wang; Zhi-Jie Li; Kun Wang; Chang-Chun Niu; Qing-Jun Yang; Xiao-Jun Tang; Yong Zhang; Xia-Mao Liu; Jin-Jing Li; De-Chun Zhang; Fan Zhang; Ping Liu; Jun Yuan; Qin Li; Jie-Li Hu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-04-29       Impact factor: 53.440

4.  Presumed Asymptomatic Carrier Transmission of COVID-19.

Authors:  Yan Bai; Lingsheng Yao; Tao Wei; Fei Tian; Dong-Yan Jin; Lijuan Chen; Meiyun Wang
Journal:  JAMA       Date:  2020-04-14       Impact factor: 56.272

5.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

6.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

8.  Emergence of a novel human coronavirus threatening human health.

Authors:  Leo L M Poon; Malik Peiris
Journal:  Nat Med       Date:  2020-03       Impact factor: 53.440

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle.

Authors:  Hongzhou Lu; Charles W Stratton; Yi-Wei Tang
Journal:  J Med Virol       Date:  2020-02-12       Impact factor: 2.327

View more
  7 in total

Review 1.  Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?

Authors:  Bao V Duong; Puchanee Larpruenrudee; Tianxin Fang; Sheikh I Hossain; Suvash C Saha; Yuantong Gu; Mohammad S Islam
Journal:  Int J Environ Res Public Health       Date:  2022-04-11       Impact factor: 4.614

2.  Prevalence of IgG antibodies induced by the SARS-COV-2 virus in asymptomatic adults in Nuevo Leon, Mexico.

Authors:  Edgar P Rodríguez-Vidales; Denise Garza-Carrillo; José J Pérez-Trujillo; Olivia A Robles-Rodríguez; Ana María Salinas-Martínez; Roberto Montes de Oca-Luna; Consuelo Treviño-Garza; Manuel E De la O-Cavazos
Journal:  J Med Virol       Date:  2021-06-16       Impact factor: 20.693

3.  Detection of IgM, IgG and SARS-CoV-2 RNA among the personnel of the University of Milan, March through May 2020: the UNICORN study.

Authors:  Gregorio Paolo Milani; Federica Rota; Chiara Favero; Laura Dioni; Alessandro Manenti; Mirjam Hoxha; Elena Pariani; Benedetta Albetti; Angela Cecilia Pesatori; Emanuele Montomoli; Valentina Bollati
Journal:  BMJ Open       Date:  2021-03-24       Impact factor: 2.692

4.  Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned.

Authors:  Mario Poljak; Anja Oštrbenk Valenčak; Erik Štrumbelj; Polona Maver Vodičar; Vasja Vehovar; Katarina Resman Rus; Miša Korva; Nataša Knap; Katja Seme; Miroslav Petrovec; Blaž Zupan; Janez Demšar; Slavko Kurdija; Tatjana Avšič Županc
Journal:  Clin Microbiol Infect       Date:  2021-04-07       Impact factor: 8.067

5.  Seroconversion dynamic and SARS-CoV-2 seropositivity in unvaccinated population during the first and second outbreaks in Mexico.

Authors:  Miguel A Fernández-Rojas; Marco A Luna-Ruiz Esparza; Abraham Campos-Romero; Diana Y Calva-Espinosa; José L Moreno-Camacho; Fela Mendlovic; Tanya Plett-Torres; Jonathan Alcántar-Fernández
Journal:  Sci Rep       Date:  2022-03-28       Impact factor: 4.379

6.  A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan.

Authors:  Saverio Bellizzi; Lora Alsawalha; Sami Sheikh Ali; Ghazi Sharkas; Nazeema Muthu; Mahmoud Ghazo; Wail Hayajneh; Maria Cristina Profili; Nathir M Obeidat
Journal:  One Health       Date:  2021-07-10

7.  Analytical and Clinical Performance of Droplet Digital PCR in the Detection and Quantification of SARS-CoV-2.

Authors:  Kyoung Bo Kim; Hayoung Choi; Gun Dong Lee; Jaewoong Lee; Seungok Lee; Yonggoo Kim; Sung-Yeon Cho; Dong-Gun Lee; Myungshin Kim
Journal:  Mol Diagn Ther       Date:  2021-07-28       Impact factor: 4.074

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.